Purpose: The purpose of this study was to compare drops of latanoprost dispensed using the Xal-Ease (Pfizer Ophthalmics, New York, New York) delivery system with drops dispensed manually.
Methods: Twenty-four 2.5-mL bottles of Xalatan (Pfizer Ophthalmics) were evaluated with or without the delivery system.